Mesa Laboratories, Inc.

NASDAQ

Market Cap.

688.17M

Avg. Volume

43.54K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Mesa Laboratories, Inc.

Mesa Laboratories, Inc. News

Mesa Laboratories, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
TechnologyHardware, Equipment & Parts
mesalabs.com

About Mesa Laboratories, Inc.

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Mesa Laboratories, Inc. Earnings & Revenue

Mesa Laboratories, Inc. Financials

Table Compare

Compare MLAB metrics with:

   

Earnings & Growth

MLAB

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

MLAB

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

MLAB

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

MLAB

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Mesa Laboratories, Inc. Income

Mesa Laboratories, Inc. Balance Sheet

Mesa Laboratories, Inc. Cash Flow

Mesa Laboratories, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioStrong Sell
Price/Earnings RatioStrong Sell
Price/Book RatioSell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Mesa Laboratories, Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

0.6400

Payment DateDividendFrequency
2025-06-160.16Quarterly
2025-03-170.16Quarterly
2024-12-160.16Quarterly
2024-09-160.16Quarterly
2024-06-140.16Quarterly

Mesa Laboratories, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Historical Market Cap

Shares Outstanding

Mesa Laboratories, Inc. Executives

NameRole
Mr. Gary M. OwensChief Executive Officer, President & Director
Mr. John V. Sakys CPAVice President, Chief Financial Officer & Chief Accounting Officer
Mr. Brian David ArchboldSenior Vice President of Continuous Improvement
NameRoleGenderDate of BirthPay
Mr. Gary M. OwensChief Executive Officer, President & DirectorMale19681.1M
Mr. John V. Sakys CPAVice President, Chief Financial Officer & Chief Accounting OfficerMale1969582.29K
Mr. Brian David ArchboldSenior Vice President of Continuous ImprovementMale1975513.64K

Mesa Laboratories, Inc. Insider Trades

Date19 Mar
NameOwens Gary M
RolePresident and CEO
TransactionAcquired
TypeM-Exempt
Shares21000
Date19 Mar
NameOwens Gary M
RolePresident and CEO
TransactionDisposed
TypeS-Sale
Shares21000
Date19 Mar
NameOwens Gary M
RolePresident and CEO
TransactionDisposed
TypeX-InTheMoney
Shares21000
Date19 Nov
NameSullivan John James
RoleDirector
TransactionDisposed
TypeG-Gift
Shares2000
Date27 Oct
NameOwens Gary M
RolePresident and CEO
TransactionAcquired
TypeA-Award
Shares11559
DateNameRoleTransactionTypeShares
19 MarOwens Gary MPresident and CEOAcquiredM-Exempt21000
19 MarOwens Gary MPresident and CEODisposedS-Sale21000
19 MarOwens Gary MPresident and CEODisposedX-InTheMoney21000
19 NovSullivan John JamesDirectorDisposedG-Gift2000
27 OctOwens Gary MPresident and CEOAcquiredA-Award11559

Discover More

Streamlined Academy

Mesa Laboratories, Inc.

NASDAQ

Market Cap.

688.17M

Avg. Volume

43.54K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Mesa Laboratories, Inc. News

Mesa Laboratories, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Mesa Laboratories, Inc. Earnings & Revenue

Mesa Laboratories, Inc. Income

Mesa Laboratories, Inc. Balance Sheet

Mesa Laboratories, Inc. Cash Flow

Mesa Laboratories, Inc. Financials Over Time

Mesa Laboratories, Inc. Executives

NameRole
Mr. Gary M. OwensChief Executive Officer, President & Director
Mr. John V. Sakys CPAVice President, Chief Financial Officer & Chief Accounting Officer
Mr. Brian David ArchboldSenior Vice President of Continuous Improvement
NameRoleGenderDate of BirthPay
Mr. Gary M. OwensChief Executive Officer, President & DirectorMale19681.1M
Mr. John V. Sakys CPAVice President, Chief Financial Officer & Chief Accounting OfficerMale1969582.29K
Mr. Brian David ArchboldSenior Vice President of Continuous ImprovementMale1975513.64K

Mesa Laboratories, Inc. Insider Trades

Date19 Mar
NameOwens Gary M
RolePresident and CEO
TransactionAcquired
TypeM-Exempt
Shares21000
Date19 Mar
NameOwens Gary M
RolePresident and CEO
TransactionDisposed
TypeS-Sale
Shares21000
Date19 Mar
NameOwens Gary M
RolePresident and CEO
TransactionDisposed
TypeX-InTheMoney
Shares21000
Date19 Nov
NameSullivan John James
RoleDirector
TransactionDisposed
TypeG-Gift
Shares2000
Date27 Oct
NameOwens Gary M
RolePresident and CEO
TransactionAcquired
TypeA-Award
Shares11559
DateNameRoleTransactionTypeShares
19 MarOwens Gary MPresident and CEOAcquiredM-Exempt21000
19 MarOwens Gary MPresident and CEODisposedS-Sale21000
19 MarOwens Gary MPresident and CEODisposedX-InTheMoney21000
19 NovSullivan John JamesDirectorDisposedG-Gift2000
27 OctOwens Gary MPresident and CEOAcquiredA-Award11559

Streamlined Academy

Website screenshot
TechnologyHardware, Equipment & Parts
mesalabs.com

About Mesa Laboratories, Inc.

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Mesa Laboratories, Inc.

Mesa Laboratories, Inc. Financials

Table Compare

Compare MLAB metrics with:

   

Earnings & Growth

MLAB

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

MLAB

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

MLAB

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

MLAB

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Mesa Laboratories, Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

0.6400

Payment DateDividendFrequency
2025-06-160.16Quarterly
2025-03-170.16Quarterly
2024-12-160.16Quarterly
2024-09-160.16Quarterly
2024-06-140.16Quarterly

Mesa Laboratories, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioStrong Sell
Price/Earnings RatioStrong Sell
Price/Book RatioSell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

A Practical Guide: How To Analyze Any Stock (With Examples)